RHEACELL GmbH & Co. KG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 2003-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.rheacell.com
Clinical Trial to Investigate Efficacy and Safety of the IMP in Patients With Non Healing Wounds Originating From Ulcers
Phase 1
Terminated
- Conditions
- Skin Ulcer Venous Stasis Chronic
- Interventions
- Biological: APZ2 application
- First Posted Date
- 2016-04-19
- Last Posted Date
- 2020-07-07
- Lead Sponsor
- RHEACELL GmbH & Co. KG
- Target Recruit Count
- 13
- Registration Number
- NCT02742844
- Locations
- 🇩🇪
Venenzentrum der Dermatologischen und Gefäßchirurgischen Kliniken, Kliniken der Ruhr-Universität Bochum im St. Maria-Hilf-Krankenhaus, Bochum, Germany
🇩🇪Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie Universitätsklinikum Würzburg, Würzburg, Germany
© Copyright 2025. All Rights Reserved by MedPath